(6-氯-5-甲基吡啶-3-基)甲醇结构式
|
常用名 | (6-氯-5-甲基吡啶-3-基)甲醇 | 英文名 | (6-CHLORO-5-METHYLPYRIDIN-3-YL)METHANOL |
---|---|---|---|---|
CAS号 | 887707-21-3 | 分子量 | 157.59800 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C7H8ClNO | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
中文名 | (6-氯-5-甲基吡啶-3-基)甲醇 |
---|---|
英文名 | (6-Chloro-5-methylpyridin-3-yl)methanol |
英文别名 | 更多 |
分子式 | C7H8ClNO |
---|---|
分子量 | 157.59800 |
精确质量 | 157.02900 |
PSA | 33.12000 |
LogP | 1.53570 |
储存条件 | 2-8°C,保存于惰性气体中 |
海关编码 | 2933399090 |
---|
~88% (6-氯-5-甲基吡啶-3-基)甲醇 887707-21-3 |
文献:Alemparte-Gallardo, Carlos; Barfoot, Christopher; Barros-Aguirre, David; Cacho-Izquierdo, Monica; Fiandor Roman, Jose Maria; Hennessy, Alan Joseph; Pearson, Neil David; Remuinan-Blanco, Modesto Jesus Patent: US2009/306089 A1, 2009 ; Location in patent: Page/Page column 26 ; |
~% (6-氯-5-甲基吡啶-3-基)甲醇 887707-21-3 |
文献:BIOGEN IDEC MA INC.; HUTCHINGS, Richard, H.; JONES, John, Howard; CHAO, Jianhua; ENYEDY, Istvan, J.; MARCOTTE, Douglas Patent: WO2014/28669 A1, 2014 ; Location in patent: Paragraph 00304 ; |
~11% (6-氯-5-甲基吡啶-3-基)甲醇 887707-21-3 |
文献:Kagabu, Shinzo Synthetic Communications, 2006 , vol. 36, # 9 p. 1235 - 1245 |
~% (6-氯-5-甲基吡啶-3-基)甲醇 887707-21-3 |
文献:Kagabu, Shinzo Synthetic Communications, 2006 , vol. 36, # 9 p. 1235 - 1245 |
~% (6-氯-5-甲基吡啶-3-基)甲醇 887707-21-3 |
文献:Kagabu, Shinzo Synthetic Communications, 2006 , vol. 36, # 9 p. 1235 - 1245 |
~% (6-氯-5-甲基吡啶-3-基)甲醇 887707-21-3 |
文献:BAYER HEALTHCARE AG Patent: WO2006/114213 A1, 2006 ; Location in patent: Page/Page column 30 ; |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
(6-chloro-5-methylpyridin-3-yl)methanol |